T1	Outcomes 42 75	mobilizing bone marrow stem cells
T2	Outcomes 300 345	mobilizes CD34(+) peripheral blood stem cells
T3	Outcomes 355 365	circulatio
T4	Outcomes 642 741	frequency of serious adverse events. Peripheral blood counts, CD34(+) count, and functional outcome
T5	Outcomes 770 840	lesion volume, atrophy, and the presence of iron-labeled CD34(+) cells
T6	Outcomes 903 917	mean of 8 days
T7	Outcomes 1151 1180	serious adverse events: G-CSF
T8	Outcomes 1228 1247	death or dependency
T9	Outcomes 1327 1409	number of injections received. G-CSF increased CD34(+) and total white cell counts
T10	Outcomes 1484 1510	MRI ischemic lesion volume
T11	Outcomes 1636 1649	CD34(+) cells